Tag Archives: Mayo v Prometheus

Tillis Bill Tries to Fix Section 101

Posted on August 8, 2022 by Warren Woessner

This recently introduced bill would replace section 101 with a lot of text. The commentators are all commentating, but I have yet to read whether or not the “outlaw” status of claims to diagnostic methods—led by varying interpretations of Mayo … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , | Leave a comment

Federal Circuit Circumvents Mayo/Alice Rule in Vanda v. West-Ward

Posted on April 17, 2018 by Warren Woessner

After Cleveland Clinic, IP practitioners were left to speculate about the fate of claims directed to methods of medical treatment. These claims seemed next in line for extinction by the Mayo/Alice rule, which I will paraphrase: “If a patent claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | Leave a comment

PLANET BLUE v. NAMCO – Abstract at the “Point of Novelty”

Posted on September 29, 2014 by Warren Woessner

In McRO, Inc. d.b.a. Planet Blue v. Namco Bandai Games America, civ. No. CV 12-10322-GW (FFMx) (C. D. Cal., Sept. 22, 2014), the granted Defendant’s motion for judgment on the pleadings that US Patent numbers 6,307,576 and 6,611, 278, were … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | 1 Comment

Genetic Technologies v. LabCorp. – Mayo Redux.

Posted on September 16, 2014 by Warren Woessner

It was Mayo redux with a vengeance in the September 23, 2014 decision in Genetic Technologies Ltd. v. Laboratory Corp. of Amer. Holdings et al., Civil Action No. 12-1736-LPS-CJB (D. Del. 2014).  Magistrate Judge Burke released an opinion invalidating claim … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , , | 2 Comments